Home » Topics » BioWorld Science

BioWorld Science
RSS

Phase I study indicates lower effective dose with [18F]PSMA-11 than other PSMA ligands

Oct. 24, 2018

Santhera begins phase Ib/IIa study of POL-6014 in cystic fibrosis

Oct. 24, 2018

Xortx's pre-IND meeting with FDA identifies accelerated clinical development plan for XRx-008

Oct. 24, 2018

First positive phase III data for PIK3CA inhibitor alpelisib in breast cancer

Oct. 24, 2018

Enanta begins phase IIa study of EDP-938 to treat RSV infection

Oct. 24, 2018

FDA agrees with Scynexis on phase III plans for ibrexafungerp in VVC

Oct. 24, 2018

Zymeworks and Leo Pharma enter licensing and research collaboration for bispecific antibodies

Oct. 24, 2018

Celgene reports PFS improvement with Revlimid in smoldering multiple myeloma

Oct. 24, 2018

Darolutamide significantly extends metastasis-free survival in nonmetastatic CRPC

Oct. 24, 2018

ADCT-602 studied in phase I/II trial for recurrent or refractory B-cell ALL

Oct. 24, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...